The evidence base of proton pump inhibitor chemopreventative agents in Barrett's esophagus--the good, the bad, and the flawed!
Gastric acid is believed to be an important etiological factor in the pathogenesis of Barrett's esophagus. Pulsatile acid exposure increases cell proliferation in ex vivo Barrrett's tissue and normalization of esophageal pH reverses this. Proton pump inhibitors (PPIs) are the mainstay of t...
主要な著者: | Leedham, S, Jankowski, J |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2007
|
類似資料
-
Proton Pump Inhibitors (PPIs): The culprit for Barrett’s esophagus?
著者:: Omran eAlsalahi, 等
出版事項: (2015-01-01) -
Barrett’s Esophagus: Is It All That Bad?
著者:: GNJ Tytgat
出版事項: (1999-01-01) -
Improving clinical outcomes of Barrett’s esophagus with high dose proton pump inhibitors and cryoablation
著者:: Harry Snady
出版事項: (2023-12-01) -
Mapping clonality in individual glands in human Barrett's esophagus
著者:: Leedham, S, 等
出版事項: (2007) -
Gingers and Their Purified Components as Cancer Chemopreventative Agents
著者:: John F. Lechner, 等
出版事項: (2019-08-01)